Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2008
[Intrapleural chemotherapy--current status and problems in Japan]Atsuko Ogino, Tetsu ShinkaiGan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[Current status of adjuvant chemotherapy for resected lung cancer at our institute--focus on clinical trial enrollment]Shigeki Sawada, Motohiro Yamashita, Eisaku Komori, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[Respiratory system]Yuka Katou, Tetsu ShinkaiAnticancer Research|August 6, 2005
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancerKatsuyuki Hotta, Nagio Takigawa, Katsuyuki Kiura, et al.Pathology International|June 4, 2009
Re-classification of pTNM staging for lung cancer: single-institution report at a Japanese comprehensive cancer hospitalNorihiro Teramoto, Rieko Nishimura, Hiroyuki Takahata, et al.Lung Cancer (Amsterdam, Netherlands)|January 13, 2009
Evaluation of lesions corresponding to ground-glass opacities that were resected after computed tomography follow-up examinationShigeki Sawada, Eisaku Komori, Naoyuki Nogami, et al.Japanese Journal of Radiology|February 8, 2012
Factors affecting survival time after recurrence of non-small-cell lung cancer treated with concurrent chemoradiotherapyYasushi Hamamoto, Masaaki Kataoka, Naoyuki Nogami, et al.Internal Medicine (Tokyo, Japan)|February 26, 2019
Portal Vein Thrombosis in a Patient with Hereditary Antithrombin DeficiencyTamao Setaka, Katsuharu Hirano, Keiichi Moriya, et al.Chest|September 16, 2005
Advanced age is not correlated with either short-term or long-term postoperative results in lung cancer patients in good clinical conditionShigeki Sawada, Eisaku Komori, Naoyuki Nogami, et al.Cancer Research|June 4, 2009
Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivoEiki Ichihara, Kadoaki Ohashi, Nagio Takigawa, et al.Pageof 7